about
Hepatitis C virus: Promising discoveries and new treatmentsVirus Variation Resource – improved response to emergent viral outbreaksHCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, CaliforniaEstimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors.Prevention and management of treatment failure to new oral hepatitis C drugs.Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting.The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease.Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohortSurvival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments.Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional study.Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.Use of injected heroin and risk of hepatitis C in three cities in Colombia.Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010.Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection.Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus
P2860
Q27468916-870A174D-C452-4115-BACC-EA434D775797Q27927644-D25B4CA8-A94C-4127-894E-65522AF5035DQ30837913-5664C62E-2415-4158-9E45-949D9B251E68Q33696050-16F8D2A8-4D32-430E-993F-7F56B0427C12Q37050953-A9B7E8EC-431E-4E6E-9240-F6CAA2A80AEEQ38826624-9F2C4058-2CFB-47E9-A255-7795D76CB350Q40053596-3E8430D2-B979-41C6-BE60-3320BE56A2FBQ40073825-23C3C164-5675-435C-B1A5-82DFCCD6B8A8Q40374154-57D7454F-1528-4C10-A823-0F8A647B69DBQ40663403-F885CF45-B167-45CA-8A82-9D001E6FC62CQ41930571-ABF9C2F9-C13B-4D76-8E4F-FCCCD8EABD6CQ45323547-D1EEE0FB-A903-4E75-90A3-1EEB82B9A833Q47267361-60F5E48E-F36B-4AD8-9FD5-A0C2ADE46084Q47546983-695D9203-FC13-4383-AD7D-4B96E12FCE92Q47574660-FFA34240-AE4A-47B2-A2AC-3479EC90134FQ47800804-56AFDF20-DC7E-4CEE-AA61-FDB26C9C4BE7Q54945179-D28123E4-0BD8-4AD3-8A11-99461F842210Q55553786-24F6A310-9C46-4BC3-BF3F-AF6A2BC38D47Q57301030-E809F7A1-F403-434F-8A03-09EB7DAEE1E7
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Natural History of Hepatitis C.
@en
Natural History of Hepatitis C.
@nl
type
label
Natural History of Hepatitis C.
@en
Natural History of Hepatitis C.
@nl
prefLabel
Natural History of Hepatitis C.
@en
Natural History of Hepatitis C.
@nl
P2860
P1476
Natural History of Hepatitis C.
@en
P2093
Marc G Ghany
Shilpa Lingala
P2860
P304
P356
10.1016/J.GTC.2015.07.003
P577
2015-08-25T00:00:00Z